Therapy of Angiogenic Eye Diseases by Novel Drug Targeting Based on Metal Coordination
Therapy of Angiogenic Eye Diseases by Novel Drug Targeting Based on Metal Coordination
批准号:
12470362
负责人:
TABATA Yasuhiko
金额:
$8.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002
中文摘要
通过近两年的研究,我们发现右旋糖酐是最好的水溶性聚合物,可用于血管生成部位的药物靶向。在葡聚糖的羟基上引入二乙烯三胺五乙酸(DTPA),制备了DTPA引入的葡聚糖螯合衍生物(DTPA-dex)。DTPA的引入比例可以通过改变反应条件来控制。在Zn ~(2+)存在下,将DTPA-dex与干扰素β(IFN β)混合,得到具有Zn ~(2+)配位的DTPA-dex-IFN偶联物。在将缀合物静脉内注射到视网膜下血管生成的兔模型中后,通过常规ELISA方法评价IFN在血管生成部位的积累。结合物注射液在兔视网膜血管生成部位的IFN量显著高于游离IFN注射液。这一发现表明,基于Zn^<2+>配位的葡聚糖缀合使IFN能够靶向动物的视网膜下血管生成部位。治疗实验表明,静脉注射DTPA-dex-IFN偶联物与Zn^<2+>配位抑制视网膜下血管生成的程度明显大于游离IFN或不含Zn^<2+>的DTPA-dex混合物。通过与葡聚糖的金属配位缀合而有效靶向血管生成位点的IFN可能导致IFN在视网膜下的上级抗血管生成作用。DTPA-dex-IFN金属配合物对不同的兔视网膜下血管生成模型具有相似的抗血管生成作用
英文摘要
Based on the research of last two years, we have found that dextran is the best watersoluble polymer which can be used for drug targeting to the angiogenic site. Diethylenetriamine pentaacetic acid (DTPA) was introduced to the hydroxyl groups of dextran to prepare DTPA-introduced dextran derivatives with chelating residues (DTPA-dex). The ratio of DTPA introduced was controllable by changing the reaction conditions. The DTPA-dex prepared was mixed in an aqueous solution with interferon (IFN) β in the presence of Zn ions to obtain the DTPA-dex-IFN conjugate with Zn^<2+> coordination. Following the intravenous injection of conjugate into a rabbit model of subretinal angiogenesis, the accumulation of IFN in the angiogenic site was evaluated by the conventional ELISA method. Significantly higher IFN amount was detected in the angiogenic site of rabbit retina for the conjugate injection than the free IFN injection. This finding indicates that the dextran conjugation based on Zn^<2+> coordination enables IFN to target to the subretinal angiogenic site of animals. Therapeutic experiments revealed that the intravenous injection of DTPA-dex-IFN conjugate with Zn^<2+> coordination suppressed the progression of subretinal angiogenesis to a significantly greater extent than that of free IFN or the mixture of DTPA-dex without Zn^<2+> ions. It is possible that efficient IFN targeting to the angiogenic site by metal coordinated conjugation with dextran results in superior anti-angiogenic effect of IFN in the subretina. The similar anti-angiogenic effect of DTPA-dex-IFN conjugate with metal coordination was observed for different rabbit models of subretinal angiogenesis
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Suginoshita, Y., Tabata, Y., Matsumura, T., Toda, Y., Nabeshima, M., Moriasu, F., Ikada, Y., Chiba, T.: "Liver targeting of human interferon-b with pullulan based on metal corrdination"J. Control. Release.. 83(1). 75-88 (2002)
Suginoshita, Y.、Tabata, Y.、Matsumura, T.、Toda, Y.、Nabeshima, M.、Moriasu, F.、Ikada, Y.、Chiba, T.:“用普鲁兰多糖靶向人干扰素-b 的肝脏
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yasukawa, T., Kimura, H., Tabata, Y., Kamizuru, H., Miyamoto, H., Honda, Y., Ogura, Y.: "Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination"Invest. Ophthalmol. Vis. Sci.. 43. 842-848 (2002)
Yasukawa, T.、Kimura, H.、Tabata, Y.、Kamizuru, H.、Miyamoto, H.、Honda, Y.、Ogura, Y.:“通过使用葡聚糖和金属协调将干扰素靶向脉络膜新生血管”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Suginoshita, Y., Tabata, Y, Matsumura, T., Toda, Y., Nabeshima, M., Moriasu, F., Ikada, Y, Chiba, T.: "Liver targeting of human interferon-b with pullulan based on metal corrdination"J. Control. Release.. 83(1). 75-88 (2002)
Suginoshita, Y., Tabata, Y, Matsumura, T., Toda, Y., Nabeshima, M., Moriasu, F., Ikada, Y, Chiba, T.:“基于支链淀粉的人干扰素-b 的肝脏靶向
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Suginoshita, Y., Tabata, Y., Moriasu, F., Y., Ikada, Chiba, T.: "Liver targeting of interferon-β with a liver affinity polysaccharide based on metal corrodination in mice"Journal of Pharmacology and Experimental Therapeutics. 298(2). 805-811 (2001)
Suginoshita,Y.,Tabata,Y.,Moriasu,F.,Y.,Ikada,Chiba,T.:“基于小鼠金属腐蚀的肝脏亲和多糖干扰素-β的肝脏靶向”药理学和实验治疗学杂志298(2)。805-811(2001)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yasukawa, T., Kimura, H., Tabata, Y., Kamizuru, H., Miyamoto, H., Honda, Y., Ogura, Y.: "Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination"Invest Ophtfaalmol. Vis. Sci.. 43. 842-848 (2002)
Yasukawa, T.、Kimura, H.、Tabata, Y.、Kamizuru, H.、Miyamoto, H.、Honda, Y.、Ogura, Y.:“通过使用葡聚糖和金属协调将干扰素靶向脉络膜新生血管”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 8 条
Creation of novel regenerative therapy technology by using macrophage recruitment
-
批准号:15K12507
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2015
-
负责人:TABATA Yasuhiko
-
依托单位:
Development of tissue engineering technology to modify biological functions for stem cell regeneration medicine
-
批准号:25242044
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$29.79万
-
财政年份:2013
-
负责人:TABATA Yasuhiko
-
依托单位:
Challenge in novel approach of regeneration therapy based on the functional modification of macrophages
-
批准号:25560194
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:TABATA Yasuhiko
-
依托单位:
Creation of functional cell aggregates confaining bioabsobable hydrogel microspheres for regenerative therapy and research
-
批准号:22650110
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.11万
-
财政年份:2010
-
负责人:TABATA Yasuhiko
-
依托单位:
Development of Technology to Manipulate the Biological Functions of Stem Cells for Cell Therapy of Next Generation
-
批准号:20220010
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$107.66万
-
财政年份:2008
-
负责人:TABATA Yasuhiko
-
依托单位:
Development of functional cell scaffolds and bioreactors for regenerative medicine based on stem cells
-
批准号:15100009
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$78.12万
-
财政年份:2003
-
负责人:TABATA Yasuhiko
-
依托单位:
Local Photodynamic Therapy of Gastrointestinal Tumors by Water-soluble Polymerized Fullerene
-
批准号:10470134
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.49万
-
财政年份:1998
-
负责人:TABATA Yasuhiko
-
依托单位:
Biomaterials incorporating releasable growth factor
-
批准号:06680854
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1994
-
负责人:TABATA Yasuhiko
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
诱导性多能干细胞rDNA区基因打靶在线粒体视神经病中的治疗研究
-
批准号:81970829
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:李卓
-
依托单位:
Pre-targeting/Click反应介导的自体循环干细胞在心脏缺血损伤修复中的应用及机制研究
-
批准号:81873493
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:沈德良
-
依托单位:
以IGF2/IGF1R与SYT/SSX1为靶点治疗滑膜肉瘤的实验研究
-
批准号:81102033
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2011
-
负责人:李大森
-
依托单位:
基于ZFN/phiC31系统的新型基因打靶技术的建立(果蝇)
-
批准号:31171278
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:高冠军
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: